• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

SOMMa Spanish research institutions to safeguard scientific competitiveness

Bioengineer by Bioengineer
March 15, 2018
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: SOMMa

The Severo Ochoa Centres and Maria de Maeztu Units Alliance (SOMMa) gathers research centres and units that received the Spanish Severo Ochoa and María de Maeztu excellence awards respectively. Thanks to the support of the Spanish State Secretariat for Research, Development and Innovation, these centres and units have joined efforts to promote, strengthen and maximise at the national and international level both the value of science of excellence produced by research centres and units, as well as its economic and social impact.

In an event held in Madrid on Monday, March 12th, representatives of SOMMa, together with the Spanish State Secretary for R+D+i, Carmen Vela, presented the new SOMMa alliance. "Spanish science comprises centres and research units of excellence that compete successfully at an international level. Uniting into this alliance allows us to join efforts, increase our impact and promote collaboration and networking. In summary, to enrich the R+D system of our country on the long run," expressed Teresa Garcia-Milà, vice-chair of SOMMa, and director of the Barcelona Graduate School of Economics (Barcelona GSE), during the presentation.

Among the objectives of the Alliance stand out: to increase the national and international visibility of Spanish research, as well as its scientific, economic and social impact; to promote the exchange of scientific knowledge and good practice between the different actors of the Spanish R+D system; to establish a dialogue with society and contribute to the nurturing of scientific culture; and to have a voice in scientific policy both in Spain and in Europe.

The full body of SOMMa centres and units gathers more than 7,000 staff dedicated to research, graduates every year more than 500 PhD candidates, and perceives funding for European projects representing an approximate turnover of 530 million Euro over a five-year period. In 2016 alone, research produced in SOMMa centres and units has been published in more than 5,800 papers in the best scientific journals, has given rise to 8 new spin-off companies, has yielded more than 100 patent applications and approximately 350 collaborations and contracts with companies. "These figures prove that the Severo Ochoa and María de Maeztu program has boosted the impact, international scientific leadership and competitiveness of these centres and units. The alliance will be very beneficial because it will allow the best centres to work together in a coordinated manner, which will contribute to expand their impact," declared the Spanish State Secretary for R+D+i, Carmen Vela.

Likewise, with the support of other organizations of the science and innovation sectors, SOMMa representatives stated their concern regarding the decrease of the R+D public funding, as well as the administrative issues constraining Spanish science. In particular, these organizations concur in highlighting the necessity to have specific, adequate regulations within the framework of European legislation safeguarding the competitiveness of the sector, as it happens in other countries.

"We acknowledge the efforts of the Spanish State Secreatariat for R+D+i to create and preserve the Severo Ochoa and María de Maeztu program despite the economic crisis and the public budget adjustments. Even so, we must insist in the importance of the investment in science, which requires a long-run State agreement," affirmed Luis Serrano, SOMMa hair and director of the Centre for Genomic Regulation (CRG).

Apart from requesting a firm commitment to uphold funding levels, SOMMa also exposes the existence of certain administrative particularities severely compromising the R+D system, which require of political will to be solved. During the event, the document "SOMMa Position Paper: Actions required to safeguarding science competitiveness" was presented, which intends to draw the attention of politicians to tackle the aforementioned issues urgently and sustainably.

In summary, the three administrative issues exposed in the report refer to the criteria for VAT deduction, the personnel hiring regulations, and the new public-tenders law . These three subjects are currently causing serious problems to a number of research centres, and can potentially affect all other research institutions of the Spanish R+D system.

The position paper proposes to reach a transversal agreement that should be backed by all parliament groups, and includes as possible solutions:

  • The consideration of research, and basic research in particular, as an economic activity, as well as to note that research is an activity of general interest, whose competitive funding should not be subject to VAT.
  • The modification of the public-tender regulations for research centres and universities adapting it to their needs, within the framework of European regulations.
  • The loosening of existing limits to the staff turnover rate, particularly for structural staff, as well as the inclusion of particular non-permanent, open-ended contract typologies. These contracts could eventually be covered with competitive funds from the State's R+D+i Grants scheme, and should not be taken into account within the staff turnover rate.

In general, the current situation affecting the research centres regarding the above mentioned administrative issues, is the result of putting research centres and universities on the same level than other public administrations, without taking into consideration the particularities and necessities of the scientific activity. "We need to have science also present in the political agenda and we hope that SOMMa will be able to work together with the Spanish Secretariat for R+D+i in that direction, for the benefit of not only the centres and units of the alliance, but of all the R+D system in Spain."

###

Media Contact

Karel W. F. De Pourcq
[email protected]
34-933-160-238
@CRGenomica

http://www.crg.es

Share12Tweet7Share2ShareShareShare1

Related Posts

Revolutionizing Brain Disease Treatment: The Hemoglobin Breakthrough

Revolutionizing Brain Disease Treatment: The Hemoglobin Breakthrough

August 22, 2025
blank

Global Study Finds Heart Disease Disproportionately Affects Racialized and Indigenous Communities, Exacerbated by Data Gaps

August 22, 2025

Brain Neurons Play Key Role in Daily Regulation of Blood Sugar Levels

August 22, 2025

Simon Family Supports Stevens INI in Advancing Global Alzheimer’s Research

August 21, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Over or Under? Navigating the Twists and Turns of Genetic Research

Revolutionizing Brain Disease Treatment: The Hemoglobin Breakthrough

G9a-Driven H3K9me2 Modification Safeguards Centromere Integrity

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.